CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 15 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $34,585,000 | -6.8% | 51,910,000 | 0.0% | 0.19% | -5.9% |
| Q2 2022 | $37,116,000 | -4.7% | 51,910,000 | 0.0% | 0.20% | +8.0% |
| Q1 2022 | $38,933,000 | +6.8% | 51,910,000 | 0.0% | 0.19% | +3.3% |
| Q4 2021 | $36,467,000 | -2.8% | 51,910,000 | 0.0% | 0.18% | +4.0% |
| Q3 2021 | $37,511,000 | -2.3% | 51,910,000 | 0.0% | 0.18% | +11.5% |
| Q2 2021 | $38,401,000 | -2.1% | 51,910,000 | 0.0% | 0.16% | -19.5% |
| Q1 2021 | $39,243,000 | +8.8% | 51,910,000 | 0.0% | 0.20% | -10.1% |
| Q4 2020 | $36,077,000 | -0.5% | 51,910,000 | 0.0% | 0.22% | -13.5% |
| Q3 2020 | $36,272,000 | +16.3% | 51,910,000 | +0.5% | 0.25% | +0.4% |
| Q2 2020 | $31,197,000 | +1.7% | 51,672,000 | +5.1% | 0.25% | -4.9% |
| Q1 2020 | $30,671,000 | +153.9% | 49,172,000 | +161.5% | 0.26% | +220.7% |
| Q4 2019 | $12,080,000 | +46.2% | 18,801,000 | 0.0% | 0.08% | +32.3% |
| Q3 2019 | $8,261,000 | -29.3% | 18,801,000 | +0.3% | 0.06% | -18.4% |
| Q2 2019 | $11,684,000 | -19.1% | 18,750,000 | 0.0% | 0.08% | -30.3% |
| Q1 2019 | $14,438,000 | +37.8% | 18,750,000 | +27.1% | 0.11% | +41.6% |
| Q4 2018 | $10,475,000 | – | 14,750,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|